|
Canada-0-MATTRESSES 公司名錄
|
公司新聞:
- Leonard S. Schleifer, MD, PhD | Regeneron CEO
Leonard S Schleifer, MD, PhD, has built and managed Regeneron since 1988 alongside his co-Founder George D Yancopoulos He is currently board co-chair, president and chief executive officer of Regeneron
- Leonard Schleifer - Wikipedia
Leonard Schleifer Leonard S Schleifer (born 1953) is an American businessman and is the co-founder and chief executive of the biotechnology company Regeneron Pharmaceuticals
- Leonard Schleifer - Forbes
Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York-based company Schleifer took Regeneron public in 1991; he owns 2% of the company's common
- Regeneron Pharmaceuticals CEO and Key Executive Team
Regeneron Pharmaceuticals CEO and Key Executive Team Regeneron Pharmaceuticals's Board Co-Chair, President and Chief Executive Officer, Founder is Leonard S Schleifer
- James Pearson - Chief Executive Officer at Regeneron Pharmaceuticals . . .
Chief Executive Officer at Regeneron Pharmaceuticals, Inc · Experience: Regeneron Pharmaceuticals, Inc · Location: Burlington View James Pearson’s profile on LinkedIn, a professional
- Regeneron CEO Dr. Leonard Schleifer on Science-Driven Success
Regeneron has pioneered innovative treatments for various diseases under the leadership of Dr Leonard Schleifer, co-chair, president, and CEO of Regeneron
- Leonard Schleifer - Society for Science
Leonard Schleifer MD, PhD is the founder, president, CEO and board co-chair of Regeneron, a biotechnology company that repeatedly translates science into medicine
- Leonard Schleifer Net Worth, Biography, and Insider Trading
Leonard S Schleifer, MD, PhD, founded Regeneron in 1988, has been a Director and the company’s President and Chief Executive Officer since its inception He served as Chairman of the Board from 1990 through 1994
- Regeneron Pharmaceuticals Org Chart + Executive Team
See the executive team of Regeneron Pharmaceuticals and its org chart, featuring 97 leaders like Leonard Schleifer, Chris Fenimore, Christina Chan and Joh
- Regeneron Pharmaceuticals - Wikipedia
In 2019, Regeneron Pharmaceuticals was announced the 7th best publicly listed company of the 2010s, with a total return of 1,457% [7] Regeneron Pharmaceuticals was home to the two highest-paid pharmaceutical executives as of 2020
|
|